We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RSKD icon
126
Riskified
RSKD
$712M
$2.59M 0.13%
552,416
-29,527
-5% -$145K
PRTH icon
127
Priority Technology Holdings
PRTH
$431M
$2.31M 0.11%
+335,881
New +$2.54M
PRKS icon
128
United Parks & Resorts
PRKS
$2B
$2.2M 0.11%
+42,633
New +$2.15M
HURC icon
129
Hurco Companies Inc
HURC
$141M
$2.2M 0.11%
126,237
-6,758
-5% -$125K
OXM icon
130
Oxford Industries
OXM
$556M
$2.16M 0.1%
53,341
-2,909
-5% -$126K
UFI icon
131
UNIFI
UFI
$129M
$2.06M 0.1%
431,971
-23,228
-5% -$107K
VRNT
132
DELISTED
Verint Systems
VRNT
$2.02M 0.1%
100,000
-966,142
-91% -$19.9M
RMAX icon
133
RE/MAX Holdings
RMAX
$243M
$2M 0.1%
211,677
-11,314
-5% -$99.9K
BXC icon
134
BlueLinx
BXC
$719M
$1.97M 0.1%
27,000
-32,956
-55% -$2.6M
JBSS icon
135
John B. Sanfilippo & Son
JBSS
$965M
$1.9M 0.09%
+29,610
New +$1.92M
MTN icon
136
Vail Resorts
MTN
$5.21B
$1.78M 0.09%
11,890
-844
-7% -$131K
TBI
137
Trueblue
TBI
$323M
$1.69M 0.08%
275,565
-14,728
-5% -$93.2K
EAF icon
138
GrafTech
EAF
$205M
$1.37M 0.07%
107,035
-3,997
-4% -$46.3K
PRPL icon
139
Purple Innovation
PRPL
$39.6M
$598K 0.03%
25,595
-1,368
-5% -$32K
MDY icon
140
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$475K 0.02%
797
– –
LEXX icon
141
Lexaria Bioscience
LEXX
$9.07M
$455K 0.02%
31,813
-1,618
-5% -$23.5K
ASHR icon
142
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$244K 0.01%
7,388
– –
CALF icon
143
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.87B
$211K 0.01%
+4,822
New +$203K
AAP icon
144
Advance Auto Parts
AAP
$3.36B
– –
-630,595
Closed -$29.3M
AMG icon
145
Affiliated Managers Group
AMG
$9.6B
– –
-22,398
Closed -$4.41M
AVDL
146
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-802,994
Closed -$7.11M
BDC icon
147
Belden
BDC
$5.28B
– –
-53,944
Closed -$6.25M
BKD icon
148
Brookdale Senior Living
BKD
$3.27B
– –
-382,321
Closed -$2.66M
CMP icon
149
Compass Minerals
CMP
$1.13B
– –
-153,576
Closed -$3.09M
CXT icon
150
Crane NXT
CXT
$2.96B
– –
-128,889
Closed -$6.95M
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.